Concord Wealth Partners’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-64
Closed -$3K 885
2022
Q2
$3K Sell
64
-323
-83% -$15.8K ﹤0.01% 956
2022
Q1
$20K Buy
387
+60
+18% +$3.1K 0.01% 632
2021
Q4
$19K Buy
327
+242
+285% +$13.9K ﹤0.01% 661
2021
Q3
$5K Sell
85
-231
-73% -$12.9K ﹤0.01% 596
2021
Q2
$16K Buy
316
+222
+236% +$11.5K ﹤0.01% 550
2021
Q1
$5K Sell
94
-95
-50% -$5.22K ﹤0.01% 677
2020
Q4
$11K Buy
+189
New +$10.1K 0.01% 358

Other funds holding QGEN

Concord Wealth Partners's QGEN Position: Q3 2022 in Review

Concord Wealth Partners sold out of Qiagen (QGEN) in Q3 2022, closing a stake of 64 shares — an estimated $3K sold.

Concord Wealth Partners first reported a position in QGEN in Q4 2020 and held it in 7 quarters. The position peaked at $20K in Q1 2022. 295 funds tracked by Wall St. Rank hold QGEN as of Q3 2022.

  • Concord Wealth Partners reported no remaining Qiagen position as of Q3 2022 after selling out during the quarter.
  • Concord Wealth Partners sold 64 Qiagen shares in Q3 2022, an estimated $3K.
  • Concord Wealth Partners first reported a position in Qiagen in Q4 2020 and held it in 7 quarters.
  • Concord Wealth Partners's Qiagen position peaked at $20K in Q1 2022.
  • 295 funds tracked by Wall St. Rank held Qiagen as of Q3 2022.

Based on Concord Wealth Partners's 13F filing for Q3 2022, filed 10 Nov 2022.